Clinical  	Clinical  	 JJ	B-NP
study  	study  	 NN	I-NP
of  	of  	 IN	I-NP
Pentraxin  	Pentraxin  	 NNP	I-NP
3  	3  	 CD	O
in  	in  	 IN	O
diagnosing  	diagnosing  	 VBG	O
the  	the  	 DT	O
severity  	severity  	 NN	O
and  	and  	 CC	O
cardiovascular  	cardiovascular  	 JJ	B-NP
function  	function  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
children  	children  	 NNS	O
with  	with  	 IN	O
sepsis  	sepsis  	 VBG	O
To  	To  	 TO	O
study  	study  	 VB	O
the  	the  	 DT	O
value  	value  	 NN	O
of  	of  	 IN	O
Pentraxin  	Pentraxin  	 NNP	B-NP
3  	3  	 CD	I-NP
( 	( 	 -LRB-	O
PTX3 	PTX3 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
diagnosing  	diagnosing  	 VBG	O
the  	the  	 DT	O
severity  	severity  	 NN	O
and  	and  	 CC	O
cardiovascular  	cardiovascular  	 JJ	B-NP
function  	function  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
critically  	critically  	 JJ	O
ill  	ill  	 JJ	O
children 	children 	 NNS	O
.  	.  	 .	O
Method  	Method  	 NN	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
178  	178  	 CD	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
were  	were  	 VBD	O
older  	older  	 JJR	O
than  	than  	 IN	O
28  	28  	 CD	O
days 	days 	 NNS	O
,  	,  	 ,	O
with  	with  	 IN	O
acute  	acute  	 JJ	O
infection  	infection  	 NN	B-NP
of  	of  	 IN	I-NP
respiratory  	respiratory  	 NN	I-NP
or  	or  	 CC	O
neurological  	neurological  	 JJ	B-NP
system 	system 	 NN	I-NP
,  	,  	 ,	O
excluding  	excluding  	 VBG	O
chronic  	chronic  	 NN	O
or  	or  	 CC	O
special  	special  	 JJ	O
disease 	disease 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
admitted  	admitted  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
pediatric  	pediatric  	 JJ	B-NP
intensive  	intensive  	 JJ	I-NP
care  	care  	 NN	I-NP
unit  	unit  	 NN	I-NP
( 	( 	 -LRB-	O
PICU 	PICU 	 NNP	B-NP
)  	)  	 -RRB-	O
of  	of  	 IN	O
Hunan  	Hunan  	 NNP	B-NP
Children 	Children 	 NNP	I-NP
's  	's  	 POS	O
Hospital  	Hospital  	 NN	O
from  	from  	 IN	O
October  	October  	 NNP	O
1 	1 	 CD	O
,  	,  	 ,	O
2013  	2013  	 CD	O
to  	to  	 TO	O
April  	April  	 NNP	O
30 	30 	 CD	O
,  	,  	 ,	O
2014  	2014  	 CD	O
were  	were  	 VBD	O
enrolled 	enrolled 	 CD	O
,  	,  	 ,	O
including  	including  	 VBG	O
102  	102  	 CD	O
male  	male  	 JJ	O
cases  	cases  	 NNS	O
and  	and  	 CC	O
76  	76  	 CD	O
female  	female  	 JJ	O
cases 	cases 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
ages  	ages  	 NNS	O
ranged  	ranged  	 VBD	O
from  	from  	 IN	O
1  	1  	 CD	O
month  	month  	 NN	O
to  	to  	 TO	O
13  	13  	 CD	O
years  	years  	 NNS	O
and  	and  	 CC	O
1  	1  	 CD	O
month 	month 	 NN	O
,  	,  	 ,	O
78  	78  	 CD	O
of  	of  	 IN	O
them  	them  	 PRP	O
were  	were  	 VBD	O
less  	less  	 JJR	O
than  	than  	 IN	O
1  	1  	 CD	O
year  	year  	 NN	O
old  	old  	 JJ	O
;  	;  	 :	O
58  	58  	 CD	O
cases  	cases  	 NNS	O
were  	were  	 VBD	O
between  	between  	 IN	O
1  	1  	 CD	O
to  	to  	 TO	O
3  	3  	 CD	O
years  	years  	 NNS	O
old 	old 	 JJ	O
;  	;  	 :	O
42  	42  	 CD	O
cases  	cases  	 NNS	O
were  	were  	 VBD	O
above  	above  	 IN	O
3  	3  	 CD	O
years  	years  	 NNS	O
old 	old 	 JJ	O
;  	;  	 :	O
101  	101  	 CD	O
cases  	cases  	 NNS	O
were  	were  	 VBD	O
diagnosed  	diagnosed  	 VBN	O
as  	as  	 IN	O
respiratory  	respiratory  	 JJ	B-NP
system  	system  	 NN	I-NP
diseases 	diseases 	 NNS	I-NP
,  	,  	 ,	O
77  	77  	 CD	O
cases  	cases  	 NNS	O
had  	had  	 VBD	O
nervous  	nervous  	 JJ	O
system  	system  	 NN	B-NP
diseases 	diseases 	 NNS	I-NP
.  	.  	 .	O
PTX3  	PTX3  	 NNP	B-NP
was  	was  	 VBD	O
detected  	detected  	 VBN	O
with  	with  	 IN	O
enzyme-linked  	enzyme-linked  	 JJ	B-NP
immunosorbent  	immunosorbent  	 JJ	I-NP
assay  	assay  	 NNS	I-NP
( 	( 	 -LRB-	O
ELISA 	ELISA 	 NNP	B-NP
)  	)  	 -RRB-	O
within  	within  	 IN	O
1  	1  	 CD	O
d  	d  	 NN	O
after  	after  	 IN	O
enrollment 	enrollment 	 NN	O
,  	,  	 ,	O
at  	at  	 IN	O
3  	3  	 CD	O
days  	days  	 NNS	O
and  	and  	 CC	O
7  	7  	 CD	O
days 	days 	 NNS	O
,  	,  	 ,	O
meanwhile 	meanwhile 	 RB	O
,  	,  	 ,	O
troponin 	troponin 	 NN	B-NP
,  	,  	 ,	O
myocardial  	myocardial  	 JJ	B-NP
enzyme 	enzyme 	 NN	I-NP
,  	,  	 ,	O
brain-type  	brain-type  	 FW	B-NP
natriuretic  	natriuretic  	 FW	I-NP
peptide  	peptide  	 FW	I-NP
( 	( 	 -LRB-	O
BNP 	BNP 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
C-reactive  	C-reactive  	 JJ	B-NP
protein  	protein  	 NN	I-NP
( 	( 	 -LRB-	O
CRP 	CRP 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
plasma  	plasma  	 FW	B-NP
calcitonin  	calcitonin  	 FW	I-NP
( 	( 	 -LRB-	O
PCT 	PCT 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
WBC  	WBC  	 NNP	B-NP
etc 	etc 	 FW	O
.  	.  	 .	O
Were  	Were  	 VBD	O
measured 	measured 	 VBN	O
.  	.  	 .	O
According  	According  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
plasma  	plasma  	 JJ	B-NP
PTX3  	PTX3  	 CD	I-NP
value  	value  	 NN	I-NP
which  	which  	 WDT	O
were  	were  	 VBD	O
measured  	measured  	 VBN	O
within  	within  	 IN	O
24  	24  	 CD	O
h  	h  	 NN	O
after  	after  	 IN	O
enrollment  	enrollment  	 VBG	O
the  	the  	 DT	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
divided  	divided  	 VBN	O
into  	into  	 IN	O
three  	three  	 CD	O
groups 	groups 	 NNS	O
:  	:  	 :	O
mildly  	mildly  	 RB	O
elevated  	elevated  	 JJ	O
group  	group  	 NN	O
(  	(  	 -LRB-	O
< 	< 	 SYM	O
44  	44  	 CD	O
µg 	µg 	 CD	B-NP
/ 	/ 	 CD	I-NP
L 	L 	 NNP	I-NP
)  	)  	 -RRB-	O
41  	41  	 CD	O
cases 	cases 	 NNS	O
;  	;  	 :	O
moderately  	moderately  	 RB	O
elevated  	elevated  	 JJ	O
group  	group  	 NN	O
( 	( 	 -LRB-	O
44  	44  	 CD	O
-  	-  	 :	O
< 	< 	 SYM	O
132  	132  	 CD	O
µg 	µg 	 CD	B-NP
/ 	/ 	 CD	I-NP
L 	L 	 NNP	I-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
66  	66  	 CD	O
cases 	cases 	 NNS	O
;  	;  	 :	O
severely  	severely  	 RB	O
elevated  	elevated  	 JJ	O
group  	group  	 NN	O
71  	71  	 CD	O
cases  	cases  	 NNS	O
( 	( 	 -LRB-	O
132  	132  	 CD	O
µg 	µg 	 CD	B-NP
/ 	/ 	 CD	I-NP
L  	L  	 NNP	I-NP
or  	or  	 CC	O
higher 	higher 	 JJR	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Those  	Those  	 DT	O
178  	178  	 CD	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
divided  	divided  	 VBN	O
into  	into  	 IN	O
3  	3  	 CD	O
groups  	groups  	 NNS	O
according  	according  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
degree  	degree  	 NN	O
of  	of  	 IN	O
infection 	infection 	 NN	B-NP
:  	:  	 :	O
non-sepsis  	non-sepsis  	 JJ	B-NP
group  	group  	 NN	I-NP
( 	( 	 -LRB-	O
78  	78  	 CD	O
cases 	cases 	 NNS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
sepsis  	sepsis  	 JJ	O
group  	group  	 NN	O
( 	( 	 -LRB-	O
70  	70  	 CD	O
cases 	cases 	 NNS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
severe  	severe  	 JJ	O
sepsis  	sepsis  	 JJ	O
group  	group  	 NN	O
( 	( 	 -LRB-	O
30  	30  	 CD	O
cases 	cases 	 NNS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
in  	in  	 IN	O
each  	each  	 DT	O
group 	group 	 NN	O
,  	,  	 ,	O
those  	those  	 DT	O
with  	with  	 IN	O
heart  	heart  	 NN	B-NP
failure  	failure  	 NN	I-NP
were  	were  	 VBD	O
respectively  	respectively  	 RB	O
19  	19  	 CD	O
cases 	cases 	 NNS	O
,  	,  	 ,	O
28  	28  	 CD	O
cases 	cases 	 NNS	O
,  	,  	 ,	O
17  	17  	 CD	O
cases 	cases 	 NNS	O
.  	.  	 .	O
Analysis  	Analysis  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
plasma  	plasma  	 JJ	B-NP
PTX3  	PTX3  	 CD	I-NP
expression  	expression  	 NN	I-NP
changes  	changes  	 NNS	I-NP
in  	in  	 IN	O
different  	different  	 JJ	O
clinical  	clinical  	 JJ	B-NP
manifestations 	manifestations 	 NNS	I-NP
,  	,  	 ,	O
different  	different  	 JJ	O
condition 	condition 	 NN	O
,  	,  	 ,	O
different  	different  	 JJ	O
degrees  	degrees  	 NNS	O
of  	of  	 IN	O
organ  	organ  	 JJ	B-NP
damages  	damages  	 NNS	I-NP
and  	and  	 CC	O
prognosis  	prognosis  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
patient 	patient 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
continuous  	continuous  	 JJ	B-NP
variables  	variables  	 NNS	I-NP
were  	were  	 VBD	O
analyzed  	analyzed  	 VBN	O
with  	with  	 IN	O
t-test 	t-test 	 NNP	B-NP
,  	,  	 ,	O
F-test 	F-test 	 NNP	B-NP
,  	,  	 ,	O
H-test 	H-test 	 NNP	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
categorical  	categorical  	 JJ	B-NP
variables  	variables  	 NNS	I-NP
were  	were  	 VBD	O
analyzed  	analyzed  	 VBN	O
with  	with  	 IN	O
Chi-square  	Chi-square  	 JJ	B-NP
test 	test 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
correlation  	correlation  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
was  	was  	 VBD	O
performed  	performed  	 VBN	O
to  	to  	 TO	O
calculate  	calculate  	 VB	O
Pearson  	Pearson  	 NNP	O
coefficients 	coefficients 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
PTX3  	PTX3  	 JJ	B-NP
value  	value  	 NN	I-NP
measured  	measured  	 VBN	O
within  	within  	 IN	O
24  	24  	 CD	O
h  	h  	 NN	O
after  	after  	 IN	O
enrollment  	enrollment  	 NN	O
increased  	increased  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
degree  	degree  	 NN	O
of  	of  	 IN	O
infection  	infection  	 NN	B-NP
( 	( 	 -LRB-	O
50.  	50.  	 CD	O
4 	4 	 CD	O
( 	( 	 -LRB-	O
35.  	35.  	 CD	O
2,70.  	2,70.  	 CD	O
4 	4 	 CD	O
)  	)  	 -RRB-	O
µg 	µg 	 FW	B-NP
/ 	/ 	 FW	I-NP
L 	L 	 NNP	I-NP
;  	;  	 :	O
175.  	175.  	 CD	O
8  	8  	 CD	O
( 	( 	 -LRB-	O
99.  	99.  	 CD	O
6 	6 	 CD	O
,  	,  	 ,	O
309.  	309.  	 CD	O
9 	9 	 CD	O
)  	)  	 -RRB-	O
µg 	µg 	 FW	B-NP
/ 	/ 	 FW	I-NP
L 	L 	 NNP	I-NP
; 	; 	 :	O
419.  	419.  	 CD	O
9  	9  	 CD	O
( 	( 	 -LRB-	O
168.  	168.  	 CD	O
3 	3 	 CD	O
,  	,  	 ,	O
468.  	468.  	 CD	O
6 	6 	 CD	O
)  	)  	 -RRB-	O
µg 	µg 	 FW	B-NP
/ 	/ 	 FW	I-NP
L 	L 	 NNP	I-NP
;  	;  	 :	O
H  	H  	 NNP	O
=  	=  	 SYM	O
88.  	88.  	 CD	O
345 	345 	 CD	O
,  	,  	 ,	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.  	0.  	 CD	O
000 	000 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
PTX3  	PTX3  	 NNP	B-NP
level  	level  	 NN	I-NP
gradually  	gradually  	 RB	O
declined 	declined 	 VBD	O
,  	,  	 ,	O
while  	while  	 IN	O
in  	in  	 IN	O
severe  	severe  	 JJ	O
sepsis  	sepsis  	 JJ	O
group  	group  	 NN	O
decreased  	decreased  	 VBD	O
slowly  	slowly  	 RB	O
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.  	0.  	 CD	O
05 	05 	 CD	O
) 	) 	 -RRB-	O
;  	;  	 :	O
the  	the  	 DT	O
area  	area  	 NN	O
under  	under  	 IN	O
the  	the  	 DT	O
ROC  	ROC  	 NNP	O
curve  	curve  	 NN	O
of  	of  	 IN	O
Plasma  	Plasma  	 NNP	B-NP
PTX3  	PTX3  	 NNP	I-NP
was  	was  	 VBD	O
larger  	larger  	 JJR	O
than  	than  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
other  	other  	 JJ	O
inflammatory  	inflammatory  	 JJ	B-NP
markers  	markers  	 JJ	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
CRP  	CRP  	 NNP	B-NP
and  	and  	 CC	O
PCT 	PCT 	 NNP	O
,  	,  	 ,	O
white  	white  	 JJ	O
blood  	blood  	 NN	O
cells  	cells  	 NNS	O
and  	and  	 CC	O
neutrophils  	neutrophils  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
diagnosis  	diagnosis  	 NN	O
of  	of  	 IN	O
sepsis 	sepsis 	 NN	O
;  	;  	 :	O
while  	while  	 IN	O
the  	the  	 DT	O
former  	former  	 JJ	O
three  	three  	 CD	O
are  	are  	 VBP	O
PTX3 	PTX3 	 RB	O
,  	,  	 ,	O
PCT  	PCT  	 NNP	O
and  	and  	 CC	O
CRP  	CRP  	 NNP	B-NP
( 	( 	 -LRB-	O
the  	the  	 DT	O
sensitivity  	sensitivity  	 NN	O
and  	and  	 CC	O
specificity  	specificity  	 VBP	O
respectively  	respectively  	 RB	O
were  	were  	 VBD	O
0.  	0.  	 CD	O
77 	77 	 CD	O
,  	,  	 ,	O
0.  	0.  	 CD	O
68 	68 	 CD	O
;  	;  	 :	O
0.  	0.  	 CD	O
66 	66 	 CD	O
,  	,  	 ,	O
0.  	0.  	 CD	O
6 	6 	 CD	O
;  	;  	 :	O
0.  	0.  	 CD	O
47 	47 	 CD	O
,  	,  	 ,	O
0.  	0.  	 CD	O
55 	55 	 CD	O
) 	) 	 -RRB-	O
;  	;  	 :	O
the  	the  	 DT	O
PTX3  	PTX3  	 JJ	B-NP
value  	value  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
severely  	severely  	 RB	O
elevated  	elevated  	 JJ	O
group  	group  	 NN	O
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
higher  	higher  	 JJR	O
than  	than  	 IN	O
those  	those  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
mildly  	mildly  	 NN	O
and  	and  	 CC	O
moderately  	moderately  	 RB	O
elevated  	elevated  	 JJ	O
groups  	groups  	 NNS	O
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.  	0.  	 CD	O
05 	05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
proportion  	proportion  	 NN	O
of  	of  	 IN	O
having  	having  	 VBG	O
3  	3  	 CD	O
or  	or  	 CC	O
more  	more  	 RBR	O
organs  	organs  	 JJ	O
failure  	failure  	 NN	O
increased  	increased  	 VBN	O
as  	as  	 IN	O
the  	the  	 DT	O
PTX3  	PTX3  	 NN	B-NP
rising  	rising  	 VBG	O
among  	among  	 IN	O
the  	the  	 DT	O
groups  	groups  	 NNS	O
of  	of  	 IN	O
mildly  	mildly  	 RB	O
elevated  	elevated  	 JJ	O
group 	group 	 NN	O
,  	,  	 ,	O
moderately  	moderately  	 RB	O
elevated  	elevated  	 JJ	O
group  	group  	 NN	O
and  	and  	 CC	O
severely  	severely  	 RB	O
elevated  	elevated  	 JJ	O
group  	group  	 NN	O
( 	( 	 -LRB-	O
1 	1 	 CD	O
( 	( 	 -LRB-	O
2.  	2.  	 CD	O
4 	4 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
4 	4 	 CD	O
( 	( 	 -LRB-	O
6.  	6.  	 CD	O
1 	1 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
14 	14 	 CD	O
( 	( 	 -LRB-	O
19.  	19.  	 CD	O
7 	7 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
χ2  	χ2  	 CD	O
=16.  	=16.  	 CD	O
16 	16 	 CD	O
, 	, 	 ,	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.  	0.  	 CD	O
000 	000 	 CD	O
) 	) 	 -RRB-	O
;  	;  	 :	O
and  	and  	 CC	O
in  	in  	 IN	O
each  	each  	 DT	O
group 	group 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
proportion  	proportion  	 NN	O
of  	of  	 IN	O
having  	having  	 VBG	O
good  	good  	 JJ	O
and  	and  	 CC	O
poor  	poor  	 JJ	O
prognosis  	prognosis  	 NN	O
for  	for  	 IN	O
these  	these  	 DT	O
three  	three  	 CD	O
groups  	groups  	 NNS	O
were  	were  	 VBD	O
different  	different  	 JJ	O
( 	( 	 -LRB-	O
33  	33  	 CD	O
( 	( 	 -LRB-	O
80.5 	80.5 	 NNP	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
8  	8  	 CD	O
( 	( 	 -LRB-	O
19.  	19.  	 CD	O
5 	5 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
35  	35  	 CD	O
( 	( 	 -LRB-	O
53 	53 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
31  	31  	 CD	O
( 	( 	 -LRB-	O
47 	47 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
28  	28  	 CD	O
( 	( 	 -LRB-	O
39.4 	39.4 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
43  	43  	 CD	O
( 	( 	 -LRB-	O
60.6 	60.6 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
χ  	χ  	 VBG	O
=  	=  	 SYM	O
17.  	17.  	 CD	O
663 	663 	 CD	O
,  	,  	 ,	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.  	0.  	 CD	O
000 	000 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
K-M  	K-M  	 JJ	B-NP
curve  	curve  	 NN	I-NP
for  	for  	 IN	O
these  	these  	 DT	O
three  	three  	 CD	O
groups  	groups  	 NNS	O
had  	had  	 VBD	O
statistically  	statistically  	 RB	O
significant  	significant  	 JJ	O
difference  	difference  	 NN	O
( 	( 	 -LRB-	O
χ2  	χ2  	 CD	O
=  	=  	 SYM	O
7.  	7.  	 CD	O
086 	086 	 CD	O
,  	,  	 ,	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.  	0.  	 CD	O
029 	029 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Those  	Those  	 DT	O
with  	with  	 IN	O
heart  	heart  	 NN	B-NP
failure  	failure  	 NN	I-NP
had  	had  	 VBD	O
higher  	higher  	 JJR	O
PTX3  	PTX3  	 NN	B-NP
value  	value  	 NN	I-NP
than  	than  	 IN	O
those  	those  	 DT	O
in  	in  	 IN	O
non-heart  	non-heart  	 JJ	B-NP
failure  	failure  	 NN	I-NP
at  	at  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
degree  	degree  	 NN	O
of  	of  	 IN	O
infection 	infection 	 NN	B-NP
.  	.  	 .	O
PTX3  	PTX3  	 NNP	B-NP
value  	value  	 NN	I-NP
increased  	increased  	 VBN	O
with  	with  	 IN	O
myocardial  	myocardial  	 JJ	B-NP
enzyme  	enzyme  	 NNS	I-NP
( 	( 	 -LRB-	O
troponin 	troponin 	 UH	B-NP
,  	,  	 ,	O
creatine  	creatine  	 FW	B-NP
kinase  	kinase  	 FW	I-NP
isoenzyme 	isoenzyme 	 FW	I-NP
,  	,  	 ,	O
BNP 	BNP 	 NNP	B-NP
)  	)  	 -RRB-	O
levels 	levels 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
diagnosis  	diagnosis  	 NN	O
of  	of  	 IN	O
heart  	heart  	 NN	B-NP
failure 	failure 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
area  	area  	 NN	O
under  	under  	 IN	O
the  	the  	 DT	O
ROC  	ROC  	 NNP	O
curve  	curve  	 NN	O
were  	were  	 VBD	O
respectively  	respectively  	 RB	O
PTX3  	PTX3  	 CD	B-NP
0.  	0.  	 CD	O
824 	824 	 CD	O
;  	;  	 :	O
BNP  	BNP  	 NNP	B-NP
0.  	0.  	 CD	O
772 	772 	 CD	O
;  	;  	 :	O
CM-KB  	CM-KB  	 JJ	B-NP
0.  	0.  	 CD	O
643 	643 	 CD	O
;  	;  	 :	O
CNTIO.  	CNTIO.  	 CD	B-NP
671 	671 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
sensitivity  	sensitivity  	 NN	O
and  	and  	 CC	O
specificity  	specificity  	 NN	O
were  	were  	 VBD	O
PTX3  	PTX3  	 CD	B-NP
0.  	0.  	 CD	O
8 	8 	 CD	O
,  	,  	 ,	O
0.  	0.  	 CD	O
58 	58 	 CD	O
;  	;  	 :	O
CK-MB  	CK-MB  	 JJ	B-NP
0.  	0.  	 CD	O
56,0.  	56,0.  	 CD	O
79 	79 	 CD	O
;  	;  	 :	O
CTNI  	CTNI  	 NNP	B-NP
0.  	0.  	 CD	O
60,0.  	60,0.  	 CD	O
69 	69 	 CD	O
;  	;  	 :	O
BNP  	BNP  	 NNP	B-NP
0.  	0.  	 CD	O
73 	73 	 CD	O
,  	,  	 ,	O
0.  	0.  	 CD	O
58 	58 	 CD	O
.  	.  	 .	O
In  	In  	 IN	O
terms  	terms  	 NNS	O
of  	of  	 IN	O
predicting  	predicting  	 VBG	O
the  	the  	 DT	O
prognosis  	prognosis  	 NN	O
of  	of  	 IN	O
sepsis  	sepsis  	 NN	O
with  	with  	 IN	O
heart  	heart  	 NN	B-NP
failure  	failure  	 NN	I-NP
complications 	complications 	 NNS	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
PTX3  	PTX3  	 JJ	B-NP
value 	value 	 NN	I-NP
's  	's  	 POS	O
area  	area  	 NN	O
under  	under  	 IN	O
ROC  	ROC  	 NNP	O
curve  	curve  	 NN	O
was  	was  	 VBD	O
larger  	larger  	 JJR	O
than  	than  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
BNP  	BNP  	 NNP	B-NP
( 	( 	 -LRB-	O
respectively  	respectively  	 RB	O
0.  	0.  	 CD	O
844 	844 	 CD	O
,  	,  	 ,	O
0.  	0.  	 CD	O
472 	472 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
PTX3  	PTX3  	 NNP	B-NP
is  	is  	 VBZ	O
an  	an  	 DT	O
objective  	objective  	 JJ	B-NP
biochemical  	biochemical  	 JJ	I-NP
marker  	marker  	 NN	I-NP
in  	in  	 IN	O
diagnosis  	diagnosis  	 NN	O
of  	of  	 IN	O
sepsis 	sepsis 	 NN	O
;  	;  	 :	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
helpful  	helpful  	 JJ	O
in  	in  	 IN	O
assessment  	assessment  	 NN	O
of  	of  	 IN	O
severity  	severity  	 NN	O
and  	and  	 CC	O
prognosis  	prognosis  	 NN	O
of  	of  	 IN	O
sepsis 	sepsis 	 NN	O
;  	;  	 :	O
it  	it  	 PRP	O
also  	also  	 RB	O
has  	has  	 VBZ	O
a  	a  	 DT	O
certain  	certain  	 JJ	O
clinical  	clinical  	 JJ	B-NP
value  	value  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
assessment  	assessment  	 NN	O
of  	of  	 IN	O
sepsis  	sepsis  	 JJ	O
cardiovascular  	cardiovascular  	 JJ	B-NP
function  	function  	 NN	I-NP
damage 	damage 	 NN	I-NP
.  	.  	 .	O
